2018
DOI: 10.17238/pmj1609-1175.2018.4.37-40
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Interleukin-17 System in Children With Allergic Bronchial Asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
0
0
Order By: Relevance
“…In the same period, duration of exacerbations decreased by 2.2-2.5 times, frequency of hospitalizations decreased by 2.0-2.5 times, duration of hospitalizations decreased by 2.3-3 times, and the need for outpatient care decreased by 1.6 timesin asthma patients and 20% (p >0.05) in the COPD patients. The obtained results are consistent with the data of other researchers who studied the vaccine efficacy against influenza in patients with bronchopulmonary pathology [41][42][43].…”
Section: Discussionsupporting
confidence: 92%
“…In the same period, duration of exacerbations decreased by 2.2-2.5 times, frequency of hospitalizations decreased by 2.0-2.5 times, duration of hospitalizations decreased by 2.3-3 times, and the need for outpatient care decreased by 1.6 timesin asthma patients and 20% (p >0.05) in the COPD patients. The obtained results are consistent with the data of other researchers who studied the vaccine efficacy against influenza in patients with bronchopulmonary pathology [41][42][43].…”
Section: Discussionsupporting
confidence: 92%